Caris Life Sciences (CAI) Inventory Average (2025 - 2026)
Caris Life Sciences (CAI) posted quarterly Inventory Average of $70.0 million for Q1 2026, up 23.9% quarter-over-quarter from $56.5 million in Q4 2025.
Powered by 
Analysis
Caris Life Sciences (CAI) Inventory Average (2025 - 2026) Analysis & Trends
Caris Life Sciences' Inventory Average history runs 2 years deep, the most recent figure standing at $70.0 million for Q1 2026.
- In Q1 2026, Inventory Average changed N/A year-over-year to $70.0 million; the TTM figure through Mar 2026 stood at $70.0 million (changed N/A YoY), while the FY2025 annual figure was $51.6 million, changed N/A from the prior year.
- Inventory Average for Q1 2026 stood at $70.0 million, up from $56.5 million in the prior quarter.
- The five-year high for Inventory Average was $70.0 million in Q1 2026, with the low at $45.0 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 3.09 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 213.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 707.10 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 90.57 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 137.65 Mn |
| 10 | Caris Life Sciences | 7.08 Bn | 6.28 Bn | 182.38 Mn | 100.04 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 100.04 Mn |
| Mar 31, 2026 | 69.96 Mn |
| Dec 31, 2025 | 56.46 Mn |
| Sep 30, 2025 | 44.96 Mn |